US Patent Issued to SK BIOPHARMACEUTICALS on Sept. 9 for "Orally disintegrated tablet comprising carbamate compound" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,164, issued on Sept. 9, was assigned to SK BIOPHARMACEUTICALS Co. LTD. (Gyeonggi-Do, South Korea).

"Orally disintegrated tablet comprising carbamate compound" was invented by Myoung Ki Baek (Gyeonggi-do, South Korea), So Young Choi (Gyeonggi-do, South Korea) and Ji Hye Lee (Gyeonggi-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an orally disintegrated tablet and a method for producing same, the tablet containing a carbamate compound of chemical formula 1, an isomer thereof, or a pharmaceutically acceptable salt, a solvate or a hydrate thereof, as an active ingredient."

The patent was filed on Dec. ...